Requisite Capital Management’s Merck MRK Stock Holding History

Requisite Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$233K	Sell	1,920 -4	-0.2%	-$462	0.04%	99
2025 Q4	$204K	Sell	1,924 -9,626	-83%	-$904K	0.04%	115
2025 Q3	$970K	Buy	+11,550	New	+$951K	0.16%	49
2024 Q1	–	Sell	-2,184	Closed	-$240K	–	84
2023 Q4	$240K	Sell	2,184 -956	-30%	-$99.2K	0.06%	62
2023 Q3	$326K	Hold	3,140	–	–	0.08%	54
2023 Q2	$365K	Hold	3,140	–	–	0.09%	47
2023 Q1	$336K	Sell	3,140 -415	-12%	-$44.8K	0.1%	41
2022 Q4	$397K	Hold	3,555	–	–	0.13%	34
2022 Q3	$309K	Hold	3,555	–	–	0.1%	38
2022 Q2	$327K	Hold	3,555	–	–	0.11%	46
2022 Q1	$294K	Buy	3,555 +514	+17%	+$40.5K	0.09%	60
2021 Q4	$235K	Hold	3,041	–	–	0.07%	70
2021 Q3	$230K	Buy	3,041 +300	+11%	+$22.8K	0.05%	76
2021 Q2	$215K	Sell	2,741 -132	-5%	-$9.82K	0.04%	76
2021 Q1	$213K	Buy	+2,873	New	+$212K	0.05%	78
2019 Q2	–	Sell	-871	Closed	-$69K	–	174
2019 Q1	$69K	Buy	+871	New	+$65.1K	0.03%	102

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Requisite Capital Management's MRK Position: Q1 2026 in Review

Requisite Capital Management reduced its Merck (MRK) stake by 0.21% in Q1 2026, selling an estimated $462 and leaving 1,920 shares worth $233K. The position accounts for 0.04% of the portfolio, ranked #99.

Requisite Capital Management first reported a position in MRK in Q1 2019 and has held it in 16 quarters since. The position peaked at $970K in Q3 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Requisite Capital Management held 1,920 shares of Merck worth $233K as of Q1 2026.
Requisite Capital Management sold 4 Merck shares in Q1 2026, an estimated $462.
Merck made up 0.04% of Requisite Capital Management's portfolio in Q1 2026, its #99 holding.
Requisite Capital Management first reported a position in Merck in Q1 2019 and has held it in 16 quarters since.
Requisite Capital Management's Merck position peaked at $970K in Q3 2025.
3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Requisite Capital Management's 13F filing for Q1 2026, filed 14 May 2026.